Filter Results :

Your search for antibod returned 134 reports

Sort by


Biosimilars Market by Product (Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Interferons, rHGH), Glycosylated (Monoclonal Antibodies, EPO), Peptides (Glucagon, Calcitonin)) & Application (Oncology, Blood Disorders) - Global Forecast to 2020

16 Jul 2015  |  Published by:  MarketsandMarkets
Report Description Various factors have contributed to the rise in demand for biopharmaceutical products such as biologics and biosimilars. Some of these factors include the rising pressure to reduce healthcare expenditure, growing demand for cost-effective alternatives, growing burden of c...

$ 4,650.00

Read More

Sinobioway - Hefei Antibody Drug Plant - Anhui - Construction Project Profile

30 Jun 2015  |  Published by:  World Market Intelligence
SynopsisThe "Sinobioway - Hefei Antibody Drug Plant - Anhui - Construction Project Profile" contains information on the scope of the project including project overview and location. The profile also details project ownership and funding, gives a full project description, as well as information on co...

$ 75.00

Read More

Global Breast Cancer Monoclonal Antibodies Market Outlook 2020

22 May 2015  |  Published by:  KuicK Research
Breast cancer incidences are increasing across the globe and conventional therapeutics have modest pharmacological efficacy. To surmount this issue, investigators came forth with monoclonal antibodies for breast cancer treatment which have targeted capabilities along with higher safety and eff...

$ 1,800.00

Read More

4-Antibody AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

15 May 2015  |  Published by:  GlobalData
Summary4-Antibody AG (4-Antibody), a subsidiary of Agenus Inc. is a biopharmaceutical company that develops antibody drug-discovery and optimization technology platform. The company discovers and develops therapeutic antibodies for the treatment of serious medical conditions such as infectious disea...

$ 250.00

Read More

Antibody Production Market by Product (Equipment, Consumables), Type (Monoclonal, Polyclonal), Technology (Hybridoma) & by End-User (Biopharmaceutical Companies, Diagnostic Labs, Research Institutes) - Analysis & Global Forecast to 2019

01 May 2015  |  Published by:  MarketsandMarkets
Over the years, the antibody production market has witnessed various technological advancements in order to produce antibodies that meet the needs of biotechnology and biopharmaceutical companies, diagnostic laboratories, and research institutes. These advancements have led to the development of hyb...

$ 5,650.00

Read More

Anti-Mucin 1 (MUC1) Antibody -Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Anti-Mucin 1 (MUC1) Antibody- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anti-Mucin 1 (MUC1) Antibody. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensi...

$ 1,250.00

Read More

Anti-CD274 (PD-L1) Antibody -Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Anti-CD274 (PD-L1) Antibody- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anti-CD274 (PD-L1) Antibody. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing...

$ 1,250.00

Read More

Anti-CD105 Antibody -Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Anti-CD105 Antibody- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anti-CD105 Antibody. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensi...

$ 1,250.00

Read More

Anti-Dickkopf-1 (Dkk-1) Antibody -Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Anti-Dickkopf-1 (Dkk-1) Antibody- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anti-Dickkopf-1 (Dkk-1) Antibody. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in...

$ 1,250.00

Read More

Anti-CD4 Antibody -Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Anti-CD4 Antibody- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anti-CD4 Antibody. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing d...

$ 1,250.00

Read More

Anti-CD3 Antibody -Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Anti-CD3 Antibody- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anti-CD3 Antibody. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing d...

$ 1,250.00

Read More

Anti-CD40 Antibody -Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Anti-CD40 Antibody- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anti-CD40 Antibody. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing...

$ 1,250.00

Read More

Anti-CD279 (PD-1) Antibody -Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Anti-CD279 (PD-1) Antibody- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anti-CD279 (PD-1) Antibody. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing a...

$ 1,250.00

Read More

The 2016 Report on AntiCD20 Monoclonal Antibodies: World Market Segmentation by City

01 Apr 2015  |  Published by:  Icon Group International, Inc
This report was created for global strategic planners who cannot be content with traditional methods of segmenting world markets. With the advent of a “borderless world”, cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report cov...

$ 995.00

Read More

The 2016-2021 World Outlook for Monoclonal Antibody (MAb)-Based Products

01 Apr 2015  |  Published by:  Icon Group International, Inc
This econometric study covers the world outlook for Monoclonal Antibody (MAb)-based products across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the perc...

$ 995.00

Read More
Total 134 records.